R&D News | pharmaphorum

News

#InvestinBiotech yearly honeycomb on green background

UK biotech investment "holding firm", says BIA

The UK life sciences raised £1.23bn in venture capital investment in the first half of 2025, although there was a fallback in the second quarter.

News

Roche expands phase 3 plans for Alzheimer's drug

Roche has added a phase 3 trial of trontinemab, hoping to show it can delay or prevent progression to Alzheimer's symptoms in preclinical patients.

News

GSK forges $12bn alliance with China's Hengrui

GSK has moved to shore up its R&D pipeline with a strategic-level partnering deal with China's Jiangsu Hengrui Pharma.

News

AZ boasts phase 3 win for self-administered gMG drug

Alexion has announced high-level positive results from a phase 3 trial of gefurulimab, a once-weekly self-administered treatment for gMG.

News

mRNA ‘wake-up call’ shows promise as universal cancer vaccin...

Researchers at the University of Florida have developed a new mRNA-based vaccine that, when combined with checkpoint inhibitor immunotherapy, significantly boosted anti-tumour activit

News

Scancell points to 'strong' melanoma vaccine data

Scancell has the results it was hoping for with its melanoma immunotherapy iSCIB1+ and is accelerating plans for a pivotal trial.

UK biotech investment "holding firm", says BIA

Roche expands phase 3 plans for Alzheimer's drug

GSK forges $12bn alliance with China's Hengrui

AZ boasts phase 3 win for self-administered gMG drug

mRNA ‘wake-up call’ shows promise as universal cancer vaccin...

Scancell points to 'strong' melanoma vaccine data

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks